A Biotech is born. You’ve chosen the founding team and identified the therapeutic and disease model. You’ve also secured a preliminary investment round. Now it’s time to beat the odds by progressing through initial milestones towards commercialization. To make it to market, you must navigate the following: Funding Milestones Early Clinical Milestones First-In-Human (IND US-CTA … Read more
Consulting Magazine recognized SSI as one of the Top 10 Best Small Firms to Work For in 2021 and 2022. SSI Strategy offers clients consulting services to support the needs of the Medical Office including, Medical Affairs, Pharmacovigilance, and Clinical Development by combining business acumen and consulting discipline to service life science industry clients.
Across the innovative therapy landscape, regulators and payers are constantly assessing the cost effectiveness of new therapies. In this issue, we highlight the importance of capturing and demonstrating value of the therapy throughout the product development lifecycle to support approval and reimbursement decisions.
SSI Strategy is thrilled to welcome Fiore Healthcare Advisors (FHA) to the team! The acquisition of Fiore Healthcare Advisors (FHA) aligns with our growth goals and further expands our Pharmacovigilance and Clinical Research offerings by onboarding a team of medical experts to further support our clients. Read The Press Release »